The MosaiQ AiPlex CD is designed to improve the accuracy and speed of celiac disease diagnosis while simplifying laboratory workflows EYSINS, Switzerland , Feb.
AliveDx seeks US FDA 510(k) premarket approval for MosaiQ AiPlex CD multiplex microarray: Eysins, Switzerland Tuesday, February 11, 2025, 12:00 Hrs [IST] AliveDx, an established c ...
Background Early-life inflammation has long been recognised as a key pathophysiological process in the evolution of cystic ...
PORTLAND, IA, UNITED STATES, February 13, 2025 /EINPresswire / -- LFIA based rapid test market is anticipated to exhibit growth owing to increase in incidence of infectious disease, rise in awareness ...
IDEAYA Biosciences, Inc. , a precision medicine oncology company committed to the discovery and development of targeted therapeutics, today announced the appointment of Joshua Bleharski, Ph.D. as ...
4d
The global respiratory diagnostics market, valued at US$ 5.85 billion in 2023, is forecasted to grow at a robust CAGR of 6.5% ...
Human Metapneumovirus (HMPV) causes respiratory infections, mainly affecting young children and the elderly. It is spread ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback